Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mural Oncology plc - Ordinary Shares (NQ: MURA )

3.520 -0.040 (-1.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mural Oncology plc - Ordinary Shares

< Previous 1 2 Next >
Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
From Mural Oncology, Inc.
Via GlobeNewswire
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
MURA Stock Earnings: Mural Oncology Reported Results for Q1 2024
Mural Oncology just reported results for the first quarter of 2024. 
Via InvestorPlace
MURA Stock Earnings: Mural Oncology Reported Results for Q4 2023
Mural Oncology just reported results for the fourth quarter of 2023. 
Via InvestorPlace
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology to Host First Virtual Investor Day on September 26, 2024
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology to Present at Two Upcoming Investor Conferences
From Mural Oncology, Inc.
Via GlobeNewswire
Why Workday Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
MURA Stock Earnings: Mural Oncology Beats EPS for Q2 2024
MURA stock results show that Mural Oncology beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.